Velcade (bortezomib)
Drug timelines are a Plus or Pro feature.
17 regulatory and trial events tracked for Velcade (bortezomib), covering 2009-06-01 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple Myeloma [Phase 2]